Amid the uproar of the COVID-19 pandemic and its new strain called Omicron, Russia is becoming cautious to protect itself from the deadly viral infection. On Monday, January 24, 2022, the Russian Health Ministry has approved the clinical tests of the vaccine against the COVID-19 virus for the children.
The vaccine that is set for the clinical trial is developed by the Gamaleya Centre of Russia, as per the information of the register of permits for clinical tests.
While emphasising the benefits of the clinical tests, the statement of the register of clinical trial reads,” The main objective of the clinical tests is that we want to ensure the safety, acceptability and potency of the vaccine made by Gamelya centre called Game-COVID-Vac M”.
The statement further mentioned the efficiency of the vaccine for the children and added,” The vaccine named Gam-COVID-Vac M is known as the combined vector vaccine and efficient against the deadly infection of novel coronavirus which is caused by the SARS-CoV-2 virus among children”.
As per the report of the register, on Monday, January 24, 2022, around 2,2000 patients will be kicked off for the clinical tests of the vaccine for the children. On the other hand, the procedures of the clinal test if the vaccine against the novel coronavirus for the children in Russian will be completed on December 31, 2023.
Moreover, the three Moscow-based medical establishments for the COVID-19 pandemic are chosen to commence the clinical trials of the vaccine.
Further, on November 29, the director of Gamaleya Centre named Alexander Ginsburg, asserted that to get permission for the conduction of the clinical tests of the vaccine against the novel coronavirus for children aged from six to eleven, the centre had filed the documents with the health ministry of Russia.
On December 6, the Health Minister of Russia, Mikhail Murashko, informed that the trials would begin in early 2022.
Further, the Russian Health Ministry also asserted that the Sputnik V vaccine is very effective against the new strain of novel coronavirus called Omicron.